Pulmonary metabolism of resveratrol: In vitro and in vivo evidence

Drug Metabolism and Disposition

Volumn 41, Issue 5, 2013, Pages 1163-1169

  Sharan, Satish ^a   Nagar, Swati ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; RESVERATROL; RESVERATROL 3 GLUCURONIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG METABOLISM; DRUG STRUCTURE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG; MALE; MICROSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE;

ANIMALS; LUNG; MALE; MICE; MICE, INBRED C57BL; STILBENES;

RODENTIA;

EID: 84876747634     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.113.051326     Document Type: Article

References (56)

1. Alex D, Leong EC, Zhang ZJ, Yan GT, Cheng SH, Leong CW, Li ZH, Lam KH, Chan SW, and Lee SM (2010) Resveratrol derivative, trans-3,5,49- trimethoxystilbene, exerts antiangiogenic and vascular-disrupting effects in zebrafish through the downregulation of VEGFR2 and cell-cycle modulation. J Cell Biochem 109:339-346.
2. Alnouti Y and Klaassen CD (2006) Tissue distribution and ontogeny of sulfotransferase enzymes in mice. Toxicol Sci 93:242-255.
3. Araki E, Ishikawa M, Iigo M, Koide T, Itabashi M, and Hoshi A (1993) Relationship between development of diarrhea and the concentration of SN-38, an active metabolite of CPT-11, in the intestine and the blood plasma of athymic mice following intraperitoneal administration of CPT-11. Jpn J Cancer Res 84:697-702.
4. Baur JA and Sinclair DA (2006) Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discov 5:493-506.
5. Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, and Gescher AJ, et al. (2007) Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 16:1246-1252.
6. Bosquillon C (2010) Drug transporters in the lung: Do they play a role in the biopharmaceutics of inhaled drugs? J Pharm Sci 99:2240-2255.
7. Brill SS, Furimsky AM, Ho MN, Furniss MJ, Li Y, Green AG, Bradford WW, Green CE, Kapetanovic IM, and Iyer LV (2006) Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms. J Pharm Pharmacol 58:469-479.
8. Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, and Piccirilli G, et al. (2010) Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: Safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res 70:9003-9011.
9. Buckley DB and Klaassen CD (2007) Tissue-and gender-specific mRNA expression of UDPglucuronosyltransferases (UGTs) in mice. Drug Metab Dispos 35:121-127.
10. Cassidy MK and Houston JB (1980) In vivo assessment of extrahepatic conjugative metabolism in first pass effects using the model compound phenol. J Pharm Pharmacol 32:57-59.
11. Cassidy MK and Houston JB (1984) In vivo capacity of hepatic and extrahepatic enzymes to conjugate phenol. Drug Metab Dispos 12:619-624.
12. Colom H, Alfaras I, Maijó M, Juan ME, and Planas JM (2011) Population pharmacokinetic modeling of trans-resveratrol and its glucuronide and sulfate conjugates after oral and intravenous administration in rats. Pharm Res 28:1606-1621.
13. Davies B and Morris T (1993) Physiological parameters in laboratory animals and humans. Pharm Res 10:1093-1095.
14. Deeley RG and Cole SP (2006) Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett 580:1103-1111.
15. Hoshino J, Park EJ, Kondratyuk TP, Marler L, Pezzuto JM, van Breemen RB, Mo S, Li Y, and Cushman M (2010) Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. J Med Chem 53:5033-5043.
16. Hutzler JM and Tracy TS (2002) Atypical kinetic profiles in drug metabolism reactions. Drug Metab Dispos 30:355-362.
17. Iwuchukwu OF and Nagar S (2008) Resveratrol (trans-resveratrol, 3,5,49-trihydroxy-transstilbene) glucuronidation exhibits atypical enzyme kinetics in various protein sources. Drug Metab Dispos 36:322-330.
18. Iwuchukwu OF, Sharan S, Canney DJ, and Nagar S (2012) Analytical method development for synthesized conjugated metabolites of trans-resveratrol, and application to pharmacokinetic studies. J Pharm Biomed Anal 63:1-8.
19. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, and Keppler D (1996) Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 56:988-994.
20. Juan ME, González-Pons E, and Planas JM (2010a) Multidrug resistance proteins restrain the intestinal absorption of trans-resveratrol in rats. J Nutr 140:489-495.
21. Juan ME, Maijó M, and Planas JM (2010b) Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC. J Pharm Biomed Anal 51:391-398.
22. Kochansky CJ, McMasters DR, Lu P, Koeplinger KA, Kerr HH, Shou M, and Korzekwa KR (2008) Impact of pH on plasma protein binding in equilibrium dialysis. Mol Pharm 5:438-448.
23. Kroemer HK and Klotz U (1992) Glucuronidation of drugs: A re-evaluation of the pharmacological significance of the conjugates and modulating factors. Clin Pharmacokinet 23:292-310.
24. Kuhnle G, Spencer JP, Chowrimootoo G, Schroeter H, Debnam ES, Srai SK, Rice-Evans C, and Hahn U (2000) Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem Biophys Res Commun 272:212-217.
25. Leslie EM, Ito K, Upadhyaya P, Hecht SS, Deeley RG, and Cole SP (2001) Transport of the beta-O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1): Requirement for glutathione or a non-sulfur-containing analog. J Biol Chem 276:27846-27854.
26. Maher JM, Slitt AL, Cherrington NJ, Cheng X, and Klaassen CD (2005) Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice. Drug Metab Dispos 33:947-955.
27. Maier-Salamon A, Hagenauer B, Reznicek G, Szekeres T, Thalhammer T, and Jäger W (2008) Metabolism and disposition of resveratrol in the isolated perfused rat liver: Role of Mrp2 in the biliary excretion of glucuronides. J Pharm Sci 97:1615-1628.
28. Meng X, Maliakal P, Lu H, Lee MJ, and Yang CS (2004) Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J Agric Food Chem 52:935-942.
29. Michael M, Brittain M, Nagai J, Feld R, Hedley D, Oza A, Siu L, and Moore MJ (2004) Phase II study of activated charcoal to prevent irinotecan-induced diarrhea. J Clin Oncol 22:4410-4417.
30. Miksits M, Maier-Salamon A, Aust S, Thalhammer T, Reznicek G, Kunert O, Haslinger E, Szekeres T, and Jaeger W (2005) Sulfation of resveratrol in human liver: Evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1. Xenobiotica 35:1101-1119.
31. Milewich L, Garcia RL, and Gerrity LW (1984) Steroid sulfatase and 17 beta-hydroxysteroid oxidoreductase activities in mouse tissues. J Steroid Biochem 21:529-538.
32. Milewich L, Garcia RL, and Johnson AR (1983) Steroid sulfatase activity in human lung tissue and in endothelial pulmonary cells in culture. J Clin Endocrinol Metab 57:8-14.
33. Mollerup S, Ovrebø S, and Haugen A (2001) Lung carcinogenesis: Resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells. Int J Cancer 92:18-25.
34. Mulder GJ, Weitering JG, Scholtens E, Dawson JR, and Pang KS (1984) Extrahepatic sulfation and glucuronidation in the rat in vivo: Determination of the hepatic extraction ratio of harmol and the extrahepatic contribution to harmol conjugation. Biochem Pharmacol 33:3081-3087.
35. Nakamura A, Nakajima M, Yamanaka H, Fujiwara R, and Yokoi T (2008) Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 36: 1461-1464.
36. Oguri T, Takahashi T, Miyazaki M, Isobe T, Kohno N, Mackenzie PI, and Fujiwara Y (2004) UGT1A10 is responsible for SN-38 glucuronidation and its expression in human lung cancers. Anticancer Res 24 (5A):2893-2896.
37. Osborne R, Joel S, Trew D, and Slevin M (1988) Analgesic activity of morphine-6-glucuronide. Lancet 1:828.
38. Patwardhan RV, Johnson RF, Hoyumpa A, Jr, Sheehan JJ, Desmond PV, Wilkinson GR, Branch RA, and Schenker S (1981) Normal metabolism of morphine in cirrhosis. Gastroenterology 81: 1006-1011.
39. Qian YM, Song WC, Cui H, Cole SP, and Deeley RG (2001) Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1. J Biol Chem 276:6404-6411.
40. Riches Z, Stanley EL, Bloomer JC, and Coughtrie MW (2009) Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: The SULT "pie." Drug Metab Dispos 37:2255-2261.
41. Scheffer GL, Pijnenborg AC, Smit EF, Müller M, Postma DS, Timens W, van der Valk P, de Vries EG, and Scheper RJ (2002) Multidrug resistance related molecules in human and murine lung. J Clin Pathol 55:332-339.
42. Segel I (1993) Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, Wiley-Interscience, New York.
43. Sharan S, Iwuchukwu OF, Canney DJ, Zimmerman CL, and Nagar S (2012) In vivo-formed versus preformed metabolite kinetics of trans-resveratrol-3-sulfate and trans-resveratrol-3-glucuronide. Drug Metab Dispos 40:1993-2001.
44. Somers GI, Lindsay N, Lowdon BM, Jones AE, Freathy C, Ho S, Woodrooffe AJ, Bayliss MK, and Manchee GR (2007) A comparison of the expression and metabolizing activities of phase I and II enzymes in freshly isolated human lung parenchymal cells and cryopreserved human hepatocytes. Drug Metab Dispos 35:1797-1805.
45. Sperker B, Backman JT, and Kroemer HK (1997) The role of beta-glucuronidase in drug disposition and drug targeting in humans. Clin Pharmacokinet 33:18-31.
46. Takasuna K, Hagiwara T, Hirohashi M, Kato M, Nomura M, Nagai E, Yokoi T, and Kamataki T (1996) Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats. Cancer Res 56:3752-3757.
47. Tracy TS and Hummel MA (2004) Modeling kinetic data from in vitro drug metabolism enzyme experiments. Drug Metab Rev 36:231-242.
48. Turgeon D, Carrier JS, Lévesque E, Hum DW, and Bélanger A (2001) Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778-787.
49. van de Wetering K, Burkon A, Feddema W, Bot A, de Jonge H, Somoza V, and Borst P (2009) Intestinal breast cancer resistance protein (BCRP)/Bcrp1 and multidrug resistance protein 3 (MRP3)/Mrp3 are involved in the pharmacokinetics of resveratrol. Mol Pharmacol 75: 876-885.
50. Yu C, Shin YG, Chow A, Li Y, Kosmeder JW, Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG, and van Breemen RB (2002) Human, rat, and mouse metabolism of resveratrol. Pharm Res 19:1907-1914.
51. Zamek-Gliszczynski MJ, Nezasa K, Tian X, Bridges AS, Lee K, Belinsky MG, Kruh GD, and Brouwer KL (2006) Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3-/-and Abcc4-/-mice. J Pharmacol Exp Ther 319:1485-1491.
52. Zelcer N, Reid G, Wielinga P, Kuil A, van der Heijden I, Schuetz JD, and Borst P (2003) Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATPbinding cassette C4). Biochem J 371:361-367.
53. Zhang L, Huang M, Blair IA, and Penning TM (2012a) Detoxication of benzo[a]pyrene-7,8-dione by sulfotransferases (SULTs) in human lung cells. J Biol Chem 287:29909-29920.
54. Zhang W, Wang X, and Chen T (2011) Resveratrol induces mitochondria-mediated AIF and to a lesser extent caspase-9-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells. Mol Cell Biochem 354:29-37.
55. Zhang W, Wang X, and Chen T (2012b) Resveratrol induces apoptosis via a Bak-mediated intrinsic pathway in human lung adenocarcinoma cells. Cell Signal 24:1037-1046.
56. Zheng Z, Fang JL, and Lazarus P (2002) Glucuronidation: An important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues. Drug Metab Dispos 30:397-403.